BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InfuSystem Holdings, Inc. (HAPN.OB) Receives Letter From NYSE MKT Regarding Timely Notice of Record Date for 2012 Annual Meeting of Stockholders


5/22/2012 10:47:08 AM

MADISON HEIGHTS, Mich., May 21, 2012 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or the "Company"), the leading provider of infusion pumps and related services, today announced that it received a letter from NYSE Regulation regarding a late notification to NYSE Amex of the "record date" for the 2012 Annual Stockholders' Meeting. The Company previously set April 30, 2012 the record date for the Company's 2012 Annual Meeting, meaning that only stockholders as of the close of business on April 30, 2012 are entitled to vote their respective shares at the Company's 2012 Annual Meeting, which is scheduled for May 25, 2012.

A company listed on the NYSE Amex is required to provide the Exchange with notice of the record date for its Annual Stockholders' meeting at least 10 days prior to the record date. InfuSystem provided late notice of the record date to the NYSE Amex. As a result, InfuSystem received a letter from NYSE Regulation on May 18, 2012, advising the Company that it did not comply with Section 703 of the NYSE Amex Company Guide, which required that the Company provide the NYSE Amex with 10 days prior notice of the April 30, 2012 record date.

Concurrently with the issuance of this press release, the Company is filing a Current Report on Form 8-K with the Securities and Exchange Commission related to this matter. The NYSE Amex advised the Company that, pursuant to Section 401(j) of the NYSE Amex Company Guide, it was required to issue a news release in respect of this matter. The Company confirms April 30, 2012 as the record date for its 2012 Annual Meeting of Stockholders, which will be held on May 25, 2012. The Company filed its proxy statement in connection with the 2012 Annual Meeting on May 7, 2012 and mailed the proxy and annual report materials to stockholders on or about May 8, 2012.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support, and also operates Centers of Excellence in Michigan, Kansas, California, and Ontario, Canada. The Company's stock is traded on the NYSE MKT under the symbol INFU.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those predicted by such forward-looking statements. These risks and uncertainties include general economic conditions, as well as other risks, detailed from time to time in the Company's publicly filed documents.

Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.

INVESTOR CONTACT:
Jonathan P. Foster
Chief Financial Officer
248-291-1210
Info@InfuSystem.com

SOURCE InfuSystem Holdings, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES